EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
September 30, 2024 -0.5654
June 30, 2024 -0.6359
March 31, 2024 -2.656
December 31, 2023 -2.548
September 30, 2023 -3.445
June 30, 2023 -7.844
March 31, 2023 -131.77
December 31, 2022 -140.60
September 30, 2022 -294.65
June 30, 2022 -510.05
March 31, 2022 -485.55
December 31, 2021 -365.40
September 30, 2021 -420.85
June 30, 2021 -402.70
March 31, 2021 -359.55
December 31, 2020 -334.70
September 30, 2020 -380.75
June 30, 2020 -444.15
March 31, 2020 -1089.00
December 31, 2019 -1450.00
September 30, 2019 -1560.25
June 30, 2019 -1761.00
March 31, 2019 -1710.30
Date Value
December 31, 2018 -1714.65
September 30, 2018 -1250.00
June 30, 2018 -1600.00
March 31, 2018 -1794.55
December 31, 2017 -2550.00
September 30, 2017 -2250.00
June 30, 2017 -2500.00
March 31, 2017 -2400.00
December 31, 2016 -2400.00
September 30, 2016 -2550.00
June 30, 2016 -2900.00
March 31, 2016 -2750.00
December 31, 2015 -2800.00
September 30, 2015 -2850.00
June 30, 2015 -2700.00
March 31, 2015 -2650.00
December 31, 2014 -2250.00
September 30, 2014 -3550.00
June 30, 2014 -2300.00
March 31, 2014 -2200.00
December 31, 2013 0.00
September 30, 2013 -16597.25
June 30, 2013 -1750.00

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ABVC BioPharma, Inc. 0.0431
Anika Therapeutics, Inc. -0.0232
Perspective Therapeutics, Inc. -0.2687
MiMedx Group, Inc. -0.0595
Abbott Laboratories 0.5294